Sign in
CompletedNo phase

Optic Nerve Sheath Diameter for Prediction of Sepsis Associated Encephalopathy

Key facts

Who runs it
Zagazig University
Where
Egypt2 sites in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
89 people enrolled
Started
3 May 2023
Ended
30 May 2024
Type of study
Observational
Treatments tested
  • Ultrasound measurement of Optic nerve sheath diameter
Record updated
4 June 2024

Who can take part

Age
21 years to 70 years
Sex
Women and men

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Patient acceptance
  • Age 21- 70 years old
  • Patients diagnosed with sepsis For diagnosis of sepsis and septic shock, the third international definition and appropriate diagnostic criteria was used; Sepsis was defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection, and it is suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Septic shock was defined as the need for vasopressors or vasoactive medication to maintain a mean arterial blood pressure of 65 mmHg or higher after adequate fluid resuscitation, with the presence of a high lactate (>2 mmol/l)

Who cannot take part

  • History of prior ocular trauma or surgery
  • Any previous neurosurgical procedure
  • Vitreous hemorrhage
  • Central nervous system (CNS) infection
  • Patient refusal
  • Ocular wound
  • Conjunctival edema or orbital edema
  • Cerebrovascular accident
  • Brain trauma

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Sepsis-associated brain dysfunction (SABD)with increased intracranial pressure is a complex pathology that can lead to unfavourable outcome. Although direct measurement of intracranial pressure using an intra-ventricular catheter remains the gold standard, it is burdened with potential serious complications due to its invasiveness. Ultrasonic measurement of optic nerve sheath diameter (ONSD) is a non-invasive method for ICP monitoring.

Read full original descriptionShow less

Screening for SABD is crucial for early diagnosis and management, measurement of ONSD can detect elevated intracranial pressure in septic patients. Intracranial hypertension in septic patients might be a sign of SABD.

Using ONSD for SABD screening requires further research. So, we hypothesized that ONSD could be used as an objective screening tool to predict and early diagnose SABD in adult septic patients.

The group in the trial

  • Adult critically ill septic patients

    Treatment: Ultrasound measurement of Optic nerve sheath diameter

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The Role of Ultrasonographic Assessment of Optic Nerve Sheath Diameter in Prediction of Sepsis Associated Encephalopathy
Publications
Record updated
4 June 2024